Biocon's syngene enters into research partnership with Bristol-Myers Squibb

Biocon Ltd on March 14, 2007 has announced that its subsidiary Company Syngene has entered into a research partnership with Bristol-Myers Squibb. Through this symbiotic global partnership, Biocon’s Syngene will provide research and development (R&D) services for discovery and early drug development.

Bristol-Myers Squibb will significantly increase the scope of its existing relationship with Biocon's Syngene to further develop integrated capabilities in India in medicinal chemistry, biology, drug metabolism, and pharmaceutical development. Under the terms of the agreement, Syngene will partner with Bristol-Myers Squibb through a dedicated research facility at Biocon Park, Bangalore, which is planned to ultimately house more than 400 scientists to help advance Bristol-Myers Squibb's discovery and early drug development.

Leveraging the current global demand for bio-partnering, this alliance aims to provide cost-effective growth and access to top scientific talent in India.

"We are delighted to announce this one-of-a-kind discovery research partnership with Bristol-Myers Squibb, a recognized global healthcare leader, said Dr. Kiran Mazumdar-Shaw, Chairperson of the Biocon Group "The new research facility will mark a significant step forward in our evolution as a valuable partner to the global pharmaceutical industry."

Syngene International Pvt Ltd (Syngene) is an internationally reputed Custom Research Company with multi-disciplinary skills in synthetic chemistry and molecular biology, Leveraging the convergence of information technology and biotechnology, Syngene conducts high value R&D in early stage drug discovery and development for a diverse global clientele.

A subsidiary of the Company, Syngene provides customised R&D services to pharmaceutical and biotechnology Companies on a strong platform of confidentiality and intellectual property protection. With state-of-the-art facilities, dedicated connectivity and highly qualified researchers, Syngene offers its customers a powerful value advantage in the field of outsourced research and development. Syngene was established in 1994.

Source : Equity Bulls

Keywords